U.S. flag

An official website of the United States government

NM_000284.4(PDHA1):c.*110C>T AND Pyruvate dehydrogenase complex deficiency

Germline classification:
Benign (1 submission)
Last evaluated:
Aug 29, 2019
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001828582.1

Allele description [Variation Report for NM_000284.4(PDHA1):c.*110C>T]

NM_000284.4(PDHA1):c.*110C>T

Gene:
PDHA1:pyruvate dehydrogenase E1 subunit alpha 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xp22.12
Genomic location:
Preferred name:
NM_000284.4(PDHA1):c.*110C>T
HGVS:
  • NC_000023.11:g.19359763C>T
  • NG_016781.1:g.20871C>T
  • NG_021184.1:g.160499G>A
  • NM_000284.4:c.*110C>TMANE SELECT
  • NM_001173454.2:c.*110C>T
  • NM_001173455.2:c.*110C>T
  • NM_001173456.2:c.*110C>T
  • NC_000023.10:g.19377881C>T
  • NM_000284.3:c.*110C>T
Links:
dbSNP: rs709610
NCBI 1000 Genomes Browser:
rs709610
Molecular consequence:
  • NM_000284.4:c.*110C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001173454.2:c.*110C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001173455.2:c.*110C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001173456.2:c.*110C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]

Condition(s)

Name:
Pyruvate dehydrogenase complex deficiency (PDHC)
Synonyms:
PDH DEFICIENCY; Pyruvate Dehydrogenase Complex Deficiency Disease; Pyruvate decarboxylase deficiency; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0019169; MedGen: C0034345; Orphanet: 765; Orphanet: 79243; OMIM: PS312170

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002076942Natera, Inc.
no assertion criteria provided
Benign
(Aug 29, 2019)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV002076942.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023